I am a breastfeeding mother and i want to know if it is safe to use Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate? Is Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate safe for nursing mother and child? Does Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate extracts into breast milk? Does Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate has any long term or short term side effects on infants? Can Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate influence milk supply or can Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate decrease milk supply in lactating mothers?
Based on its physicochemical properties and extremely short half-life, Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate would not be expected to cause any adverse effects in breastfed infants.
A study of mothers taking beta-blockers during nursing found a numerically, but not statistically significant increased number of adverse reactions in those taking any beta-blocker. Although the ages of infants were matched to control infants, the ages of the affected infants were not stated. None of the mothers were taking Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate.[2]
Relevant published information on the effects of beta-blockade or Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate during normal lactation was not found as of the revision date. A study in 6 patients with hyperprolactinemia and galactorrhea found no changes in serum prolactin levels following beta-adrenergic blockade with propranolol.[3]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.